Zevra Therapeutics, Inc. (ZVRA)

9.03 +0.01 (+0.11%) USD  |  NASDAQ  |  Jan 21, 16:00
9.01 -0.02 (-0.22%) Pre-Market: 08:29
More

Zevra Therapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade